title: Therapeutic Particles and Biomaterials Technology Laboratory at the University of Kansas.
abstract: Novel technologies to enhance therapeutic delivery and biomaterial performance are fundamental to the development of improved products with fewer unwanted side effects. The Therapeutic Particles and Biomaterials Technology Laboratory at The University of Kansas (KS, USA) works at the interface of medicine and engineering to develop novel materials that enhance therapeutic delivery in a variety of biomedical applications. Research areas include aerosol drug delivery, targeted nanoparticles for drug and contrast agent delivery, biomaterials for tissue engineering and polymer therapeutics. The lab works with industry, academia and law firms through a variety of mechanisms such as fee-for-service, contract research and collaboration. Ultimately, the group aims to develop materials and drug delivery platforms that are fundamentally unique yet simple solutions to improve human health.
authors: Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, KS 66047, USA.
authors: Mark M
authors: MM
authors: Bailey
authors: Cory
authors: C
authors: Berkland
mesh_terms: D000336:Aerosols; D000818:Animals; D001672:Biocompatible Materials; D002626:Chemistry, Pharmaceutical; D003102:Colloids; D003287:Contrast Media / Q000008:administration & dosage* / Q000737:chemistry; D003692:Delayed-Action Preparations; D004333:Drug Administration Routes; D004337:Drug Carriers; D004339:Drug Compounding; D018014:Gene Transfer Techniques; D006801:Humans; D007615:Kansas; D007753:Laboratories; D053758:Nanoparticles; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000737:chemistry; D013678:Technology, Pharmaceutical / Q000379:methods; D054457:Tissue Scaffolds; D014495:Universities
chemical_list: D000336:Aerosols; D001672:Biocompatible Materials; D003102:Colloids; D003287:Contrast Media; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D004364:Pharmaceutical Preparations